382 related articles for article (PubMed ID: 24100728)
1. Zollinger-Ellison syndrome: recent advances and controversies.
Ito T; Igarashi H; Jensen RT
Curr Opin Gastroenterol; 2013 Nov; 29(6):650-61. PubMed ID: 24100728
[TBL] [Abstract][Full Text] [Related]
2. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
[TBL] [Abstract][Full Text] [Related]
3. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.
Rossi RE; Elvevi A; Citterio D; Coppa J; Invernizzi P; Mazzaferro V; Massironi S
World J Gastroenterol; 2021 Sep; 27(35):5890-5907. PubMed ID: 34629807
[TBL] [Abstract][Full Text] [Related]
4. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999].
Mignon M
Bull Acad Natl Med; 2003; 187(7):1249-58; discussion 1259-60. PubMed ID: 15146602
[TBL] [Abstract][Full Text] [Related]
6. The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach.
Pisegna JR
Curr Gastroenterol Rep; 1999 Dec; 1(6):511-7. PubMed ID: 10980995
[TBL] [Abstract][Full Text] [Related]
7. Current diagnosis and management of Zollinger-Ellison syndrome.
Andersen DK
Ann Surg; 1989 Dec; 210(6):685-703. PubMed ID: 2686566
[TBL] [Abstract][Full Text] [Related]
8. Gastrinoma: advances in localization and treatment.
Norton JA
Surg Oncol Clin N Am; 1998 Oct; 7(4):845-61. PubMed ID: 9735137
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
[TBL] [Abstract][Full Text] [Related]
10. Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma.
Jensen RT; Fraker DL
JAMA; 1994 May; 271(18):1429-35. PubMed ID: 7513768
[No Abstract] [Full Text] [Related]
11. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.
Norton JA; Jensen RT
Ann Surg; 2004 Nov; 240(5):757-73. PubMed ID: 15492556
[TBL] [Abstract][Full Text] [Related]
12. Review article: the management of Zollinger-Ellison syndrome.
Maton PN
Aliment Pharmacol Ther; 1993 Oct; 7(5):467-75. PubMed ID: 7904187
[TBL] [Abstract][Full Text] [Related]
13. [Management of gastrinoma].
Hain E; Coriat R; Dousset B; Gaujoux S
Presse Med; 2016 Nov; 45(11):986-991. PubMed ID: 27262229
[TBL] [Abstract][Full Text] [Related]
14. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.
Pipeleers-Marichal M; Donow C; Heitz PU; Klöppel G
World J Surg; 1993; 17(4):481-8. PubMed ID: 8103250
[TBL] [Abstract][Full Text] [Related]
15. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
Richards ML; Gauger P; Thompson NW; Giordano TJ
World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
[TBL] [Abstract][Full Text] [Related]
16. Gastrinomas: advances in diagnosis and management.
Jensen RT
Neuroendocrinology; 2004; 80 Suppl 1():23-7. PubMed ID: 15477712
[TBL] [Abstract][Full Text] [Related]
17. Zollinger-Ellison syndrome: past, present and future controversies.
Jensen RT
Yale J Biol Med; 1994; 67(3-4):195-214. PubMed ID: 7502529
[TBL] [Abstract][Full Text] [Related]
18. Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion.
Gibril F; Jensen RT
Curr Gastroenterol Rep; 2004 Dec; 6(6):454-63. PubMed ID: 15527675
[TBL] [Abstract][Full Text] [Related]
19. Zollinger-Ellison syndrome: classical considerations and current controversies.
Epelboym I; Mazeh H
Oncologist; 2014 Jan; 19(1):44-50. PubMed ID: 24319020
[TBL] [Abstract][Full Text] [Related]
20. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
